Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Merck, SmithKline and patents

Nature volume 381, page 360 (1996)Cite this article

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Poste, G. Nature 378, 534–536; 1995.

    Article  ADS  CAS  Google Scholar 

  2. Elliston, K. & Williamson, A. Nature 372, 10 (1994).

    ADS  PubMed  Google Scholar 

  3. 35 U.S.C. §§ 100–103.

  4. United States Constitution, Article I, Section 8, Clause 8 (1789).

  5. Adams, M. D. et. al. Nature 377 Suppl., 3–174 (1995).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Merck Research Laboratories, Merck & Co. Inc, PO Box 2000, RY80K, Rahway, New Jersey, 07065-0900, USA

    C. Thomas Caskey & Alan R. Williamson

Authors
  1. C. Thomas Caskey
    View author publications

    Search author on:PubMed Google Scholar

  2. Alan R. Williamson
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caskey, C., Williamson, A. Merck, SmithKline and patents. Nature 381, 360 (1996). https://doi.org/10.1038/381360a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/381360a0

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing